NUBAIN

This brand name is authorized in Austria, Brazil, Canada.

Active ingredients

The drug NUBAIN contains one active pharmaceutical ingredient (API):

1	Nalbuphine UNII ZU4275277R - NALBUPHINE HYDROCHLORIDE
	Nalbuphine is an opioid with kappa-agonistic and mu-antagonistic properties. Beside the essential agonistic (analgesic) effect nalbuphine has antagonistic effects of about a fourth of nalorfine and ten times of pentazocine.
	Read more about Nalbuphine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NUBAIN Solution for injection	MPI, CA: SPM	Health Products and Food Branch (CA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02AF02	Nalbuphine	N Nervous system → N02 Analgesics → N02A Opioids → N02AF Morphinan derivatives
Discover more medicines within N02AF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	506712101153413, 506715030057703, 506717040068403
CA	Health Products and Food Branch	01913980